CompoAtlas

Aveeno Soothing Bath Treatment

Natural health product licensed in Canada

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Avena sativa

Source : Graine(s)

100 % (p/p)

Non-medicinal ingredients

Not provided.

PopulationAgeQuantity per servingFrequency
Sous-population S/ONot specified42,000 mg1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Temporarily protects and helps relieve minor skin irritation and itching due to rashes, eczema, poison ivy, poison oak or poison sumac and insect bites. Helps relieve minor skin irritations and dry, itchy skin.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Product record

Licence holder
Kenvue Canada Inc.
NPN or DIN-HM
02240107
Status
Active licence
Licence date
10 March 2008
Revision date
Not provided
Form
Poudre
Route of administration
Topique
Application type
DIN de transition

Source

Official Health Canada record, licence 02240107

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Aveeno Soothing Bath Treatment”, https://compoatlas.com/en/supplements/canada/02240107-aveeno-soothing-bath-treatment, updated 10 March 2008.

Enter to analyse, Shift+Enter for a new line